Diamond-Blackfan anemia (DBA) is a rare, life-threatening genetic blood ... Stem cell transplants, the only potential cure, ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...

Anemia, a condition characterized by a reduction in red blood cells or hemoglobin, limits oxygen transport within the body.

Sickle cell anemia requires ongoing, lifelong treatment to improve quality of life and prevent complications. Treatment of sickle cell anemia includes taking measures to treat anemia, prevent ...

Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Saeed Sadeghi, MD, explores the future treatment landscape for anemia in lower-risk myelodysplastic syndromes (LR-MDS), ...

The results showed that 19.1% of older adults were using low-dose aspirin and among the users, 9.6% exhibited hematinic deficiency, necessitating antianemic treatments, compared to only 3.7% in ...

Canada NewsWire MISSISSAUGA, ON, Nov. 12, 2024 MISSISSAUGA, ON, Nov. 12, 2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment o ...